Limits...
ISBT 128: a global information standard.

Distler P - Cell Tissue Bank (2010)

Bottom Line: The system has been designed and perfected over almost two decades to ensure accuracy, safety and efficiency for the benefit of donors, patients and health care workers worldwide.Advisory groups comprising international experts guide the ongoing development of the ISBT 128 standard to ensure it continues to meet the needs of its users.While there is a cost associated with the implementation and use of the standard, the clear benefits in terms of improved patient safety and ability to meet regulatory traceability requirements justify the costs.

View Article: PubMed Central - PubMed

Affiliation: International Council for Commonality in Blood Banking Automation, San Bernardino, CA, USA. pat.distler@iccbba.org

ABSTRACT
ISBT 128 is the global standard for the identification, labeling and information transfer of human blood, cell, tissue and organ products across international borders and disparate health care systems. The system has been designed and perfected over almost two decades to ensure accuracy, safety and efficiency for the benefit of donors, patients and health care workers worldwide. The use of the ISBT 128 standard has grown steadily since a blood bank in Estonia first implemented it in 1997. Today, more than 3,500 facility identifiers for the use of ISBT 128 have been assigned to organizations in 67 countries on six continents. The standard has been accepted by a variety of international standard setting organizations and government regulators. It is managed by ICCBBA, a not-for-profit organization based in the USA that is governed by an international volunteer board of directors. Members of the Board of Directors represent the fields of practice affected by the standard. Advisory groups comprising international experts guide the ongoing development of the ISBT 128 standard to ensure it continues to meet the needs of its users. While there is a cost associated with the implementation and use of the standard, the clear benefits in terms of improved patient safety and ability to meet regulatory traceability requirements justify the costs.

Show MeSH
Donation identification number
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3012209&req=5

Fig1: Donation identification number

Mentions: A key benefit of ISBT 128 is the assignment of identifiers to products that are unique globally for 100 years. Each identifier (Donation Identification Number or DIN) has three parts: (1) a five-character Facility Identification Number (FIN) assigned by ICCBBA, (2) a two-character year and (3) a six-character serial number assigned by the facility. (See Fig. 1). These globally unique identifiers eliminate the need to renumber products and thereby simplify and strengthen the traceability process.Fig. 1


ISBT 128: a global information standard.

Distler P - Cell Tissue Bank (2010)

Donation identification number
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3012209&req=5

Fig1: Donation identification number
Mentions: A key benefit of ISBT 128 is the assignment of identifiers to products that are unique globally for 100 years. Each identifier (Donation Identification Number or DIN) has three parts: (1) a five-character Facility Identification Number (FIN) assigned by ICCBBA, (2) a two-character year and (3) a six-character serial number assigned by the facility. (See Fig. 1). These globally unique identifiers eliminate the need to renumber products and thereby simplify and strengthen the traceability process.Fig. 1

Bottom Line: The system has been designed and perfected over almost two decades to ensure accuracy, safety and efficiency for the benefit of donors, patients and health care workers worldwide.Advisory groups comprising international experts guide the ongoing development of the ISBT 128 standard to ensure it continues to meet the needs of its users.While there is a cost associated with the implementation and use of the standard, the clear benefits in terms of improved patient safety and ability to meet regulatory traceability requirements justify the costs.

View Article: PubMed Central - PubMed

Affiliation: International Council for Commonality in Blood Banking Automation, San Bernardino, CA, USA. pat.distler@iccbba.org

ABSTRACT
ISBT 128 is the global standard for the identification, labeling and information transfer of human blood, cell, tissue and organ products across international borders and disparate health care systems. The system has been designed and perfected over almost two decades to ensure accuracy, safety and efficiency for the benefit of donors, patients and health care workers worldwide. The use of the ISBT 128 standard has grown steadily since a blood bank in Estonia first implemented it in 1997. Today, more than 3,500 facility identifiers for the use of ISBT 128 have been assigned to organizations in 67 countries on six continents. The standard has been accepted by a variety of international standard setting organizations and government regulators. It is managed by ICCBBA, a not-for-profit organization based in the USA that is governed by an international volunteer board of directors. Members of the Board of Directors represent the fields of practice affected by the standard. Advisory groups comprising international experts guide the ongoing development of the ISBT 128 standard to ensure it continues to meet the needs of its users. While there is a cost associated with the implementation and use of the standard, the clear benefits in terms of improved patient safety and ability to meet regulatory traceability requirements justify the costs.

Show MeSH